✦ LIBER ✦

[683] THERAPY OF CHRONIC HEPATITIS C WITH INTERFERON AND RIBAVIRIN - DOES IT INCREASE THE INCIDENCE OF TYPE 2 DIABETES MELLITUS?

✍ Scribed by N. Hilzenrat; K. Al-Sayari; I. Shrier; T. Kader; M. Deschenes

Book ID: 117375774
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 145 KB
Volume: 46
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(07)62281-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Onset of Type 1 Diabetes Mellitus During

Onset of Type 1 Diabetes Mellitus During Pegylated-interferon Alfa and Ribavirin Therapy for Chronic Hepatitis C Virus Infection

✍ Raghini Ranganathan; Krishnaveni Janarthanan; Senthilkumar Rajasekaran 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 129 KB

Diabetes mellitus reduces the therapeuti

Diabetes mellitus reduces the therapeutic effectiveness of interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C

✍ Ichiro Konishi; Norio Horiike; Yoichi Hiasa; Yoshio Tokumoto; Toshie Mashiba; Ko 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Dual onset of type 1 diabetes mellitus a

Dual onset of type 1 diabetes mellitus and Graves’ disease during treatment with pegylated interferon α-2b and ribavirin for chronic hepatitis C

✍ Masayuki Hayashi; Yuko Kataoka; Kazushige Tachikawa; Hiroki Koguchi; Hiroshi Tan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Impact of diabetes mellitus on incidence

Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy

✍ Chao-Hung Hung; Chuan-Mo Lee; Jing-Houng Wang; Tsung-Hui Hu; Chien-Hung Chen; Ch 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 644 KB

## Abstract There is strong evidence linking chronic hepatitis C virus (HCV) infection and Type 2 diabetes mellitus (DM). Recent studies have suggested that DM is associated with increased risk of developing hepatocellular carcinoma (HCC). The aim of our cohort study was to assess whether DM influe

Comparison between combination therapy w

Comparison between combination therapy with peg-interferon alfa-2A plus ribavirin and peg-interferon alfa-2B plus ribavirin in the treatment of chronic hepatitis C

✍ M. Capanni; M.R. Biagini; S. Nanni; E. Lorefice; M. Paci; M.C. Benini; E. Gai; A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 111 KB

High incidence of type 1 diabetes mellit

High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon α for chronic hepatitis C virus infection

✍ Tim C. M. A. Schreuder; Huub C. Gelderblom; Christine J. Weegink; Dörte Hamann; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB